The strong correlation between severity of diabetic retinopathy and cardiovascular events could help ophthalmologists motivate affected patients with type 2 diabetes to see a primary care provider. Medscape Medical News
Author: Medscape
The Dangers of an Unwitnessed Pandemic
This, Dr. Weiss wrote in his day four entry, is the reality of the disease: ‘You really can’t understand till you see it…and that’s the problem. Nobody is seeing it.’ Undark
Med Students and Doctors Shouldn’t Sell Advice
Increased competition among medical school applicants has led to a boom in premed advising companies. Here’s why med students and faculty shouldn’t sell advice through these services. Medscape Med Students
What Does the Case Fatality Rate Really Tell Us?
There are two big problems with the case fatality rate metric, says Dr F. Perry Wilson. What we really want to know is the infection fatality rate. What’s the difference? Medscape
OCT Angiography a Good Way to Detect Diabetic Retinopathy
Wide-field swept-source optical coherence tomography angiography can detect key features of diabetic retinopathy, in a much less-invasive manner than common alternatives, researchers report. Medscape Medical News
What Docs Hate: Every Specialty Has Its Thing
A recent lively discussion on Twitter encouraged clinicians in all specialties to note the one thing that most gets their hackles up. Some of them will surprise you. Medscape Family Medicine
As Ophthalmology Clinics Reopen, New Questions Abound
Dr Sumit (Sam) Garg discusses navigating our disorienting new normal. Medscape Ophthalmology
Fauci: ‘The Virus Is a Formidable Foe’
Dr Anthony Fauci discusses the COVID-19 pandemic, the US response, and the outlook for a vaccine to combat the virus. WebMD
Fauci to Medscape: ‘We’re Gonna Get Through It’
In a discussion with Eric Topol and Abraham Verghese, Anthony Fauci describes how we’ll make it through the pandemic as a country and scientific community. Medscape
Ophthalmologists Called to Catch Cancers Earlier
Advances in the management of common eye cancers have highlighted the need for early treatment, experts say. Medscape Medical News
ASRS 2020
Read clinically focused news coverage of key developments from ASRS 2020 Medscape Ophthalmology
Does Less Medical Care Mean Better Care?
A fellow cardiologist comes to the defense of New York Times contributor Sandeep Jauhar, who was castigated on social media for suggesting that most people were fine with fewer doctor visits. theheart.org on Medscape
Rubber Bullets, Tear Gas: What Doesn’t Kill Can Still Blind
Use of rubber bullets and tear gas during the recent protests has led to significant eye injuries. Dr Ann Murchison offers guidance on appropriate ocular management in the midst of a pandemic. Wills Eye Hospital
Should We Treat or Observe DME With Good Vision?
Treating all patients with central-involved diabetic macular edema, regardless of their vision quality, may not be a clinically effective strategy. Medscape Ophthalmology
COVID-19 Status Should Influence Noninfectious Uveitis Treatment Decisions
In patients with noninfectious uveitis, the individual’s COVID-19 status should influence decisions regarding immunomodulatory therapy, according to a survey-based study. Reuters Health Information
When a White Coat and Badge Don’t Protect You
Samuel Kebede is a Black internal medicine resident who is often mistaken for cleaning staff or asked to show his ID. “Racism permeates all institutions,” he says. ”Medicine is not immune.” Medscape Internal Medicine
Patients Who Refuse Masks: Responses That Won’t Get You Sued
A patient refuses to wear a mask in your office. Can you refuse to provide care? Medscape Family Medicine
Yes, Current COVID Infection Fatality Rates Are a Big Deal
Some have argued that rising COVID-19 infection rates in young people are no big deal because death rates are falling. A closer look at data tells a concerning story. Medscape Internal Medicine
Artificial Intelligence Passes Macular Degeneration Test
A deep-learning system accurately diagnosed age-related macular degeneration in a real-life population in a prospective clinical trial. Medscape Medical News
Bimatoprost Implant a Promising Weapon in Fight Against Glaucoma
Dr Shuchi Patel says the important question behind the recently approved intracameral biodegradable sustained-release implant isn’t whether it works (it does) but rather for how long. Medscape Ophthalmology